米诺环素作为神经保护剂对抗特拉马多尔诱导的神经退行:行为和分子证据
相关实验视频
Updated: Jun 7, 2025

05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
28.5K
Mina Gholami1, Zahra Ghelichkhani2, Reza Aghakhani3
1Chronic Respiratory Disease Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
International journal of preventive medicine
|November 14, 2024
概括
米诺环素 (MIN) 通过减少氧化应激,炎症和亡,有效地保护特拉马多尔 (TRA) 诱导的神经退行. 这项研究强调了MIN MIN.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 特拉马多尔 (TRA) 与神经退行性影响有关.
- 米诺环素 (MIN) 具有已知的神经保护性.
研究的目的:
- 调查米诺环素 (MIN) 对特拉马多尔 (TRA) 诱导的神经退行症的神经保护潜力.
- 评估MIN对TRA诱导的行为,生化和组织形态变化的影响.
主要方法:
- 成年雄性大鼠被给予TRA和MIN的不同剂量,持续21天.
- 使用开放场测试 (OFT) 评估运动活动和焦虑.
- 评估了氧化应激,炎症,亡,线粒体功能和海马体组织形态学.
主要成果:
- MIN治疗显著抑制了TRA诱导的焦虑和运动缺陷.
- MIN减弱了氧化应激 (ROS,H2O2,GSSG,MDA) 和炎症 (TNF-α,IL1-β) 的标志物.
- MIN改善了线粒体功能 (ATP,MMP,复杂活动) 并减少了亡 (BAX,CASP3),恢复了海马体结构.
结论:
- 米诺环素 (MIN) 显示出对特拉马多尔 (TRA) 诱导的神经退行症的显著神经保护作用.
- MIN可能通过调节炎症,氧化应激,亡和线粒体功能障碍来发挥作用.
- 这些发现表明MIN在减轻TRA诱导的神经毒性方面的潜在治疗作用.
相关概念视频
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K

